SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001047469-98-015580
Filing Date
1998-04-17
Accepted
1998-04-17 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 15645
  Complete submission text file 0001047469-98-015580.txt   17834
Mailing Address 365 PLANTATION STREET WORCESTER MA 01605
Business Address 365 PLANTATION STREET WORCESTER MA 01605 5087975777
AQUILA BIOPHARMACEUTICALS INC (Subject) CIK: 0000704292 (see all company filings)

IRS No.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35873 | Film No.: 98596646
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice